NRBP2
Nuclear receptor-binding protein 2
Also known as: DKFZp434P086, NRBP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NSY0
- Gene
- NRBP2
- Ensembl
- ENSG00000185189
- Chromosome
- 8
- Canonical length
- 501 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable protein serine/threonine kinase activity. Involved in negative regulation of macroautophagy. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
501 residues, UniProt reviewed canonical sequence.
>Q9NSY0|NRBP2
1 MAAPEPAPRR ARERERERED ESEDESDILE ESPCGRWQKR REQVNQGNMP GLQSTFLAMD
61 TEEGVEVVWN ELHFGDRKAF AAHEEKIQTV FEQLVLVDHP NIVKLHKYWL DTSEACARVI
121 FITEYVSSGS LKQFLKKTKK NHKAMNARAW KRWCTQILSA LSFLHACSPP IIHGNLTSDT
181 IFIQHNGLIK IGSVWHRIFS NALPDDLRSP IRAEREELRN LHFFPPEYGE VADGTAVDIF
241 SFGMCALEMA VLEIQTNGDT RVTEEAIARA RHSLSDPNMR EFILCCLARD PARRPSAHSL
301 LFHRVLFEVH SLKLLAAHCF IQHQYLMPEN VVEEKTKAMD LHAVLAELPR PRRPPLQWRY
361 SEVSFMELDK FLEDVRNGIY PLMNFAATRP LGLPRVLAPP PEEVQKAKTP TPEPFDSETR
421 KVIQMQCNLE RSEDKARWHL TLLLVLEDRL HRQLTYDLLP TDSAQDLASE LVHYGFLHED
481 DRMKLAAFLE STFLKYRGTQ ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NRBP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 95 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 95 nTPM
- midbrain: 42 nTPM
- hippocampal formation: 33 nTPM
- liver: 33 nTPM
- cerebral cortex: 29 nTPM
- amygdala: 28 nTPM
Single-cell type
- astrocytes: 91 nCPM
- ependymal cells: 84 nCPM
- bergmann glia: 57 nCPM
- oligodendrocytes: 57 nCPM
- tuft cells: 46 nCPM
- pituicytes/fscs: 37 nCPM
Immune cell
- MAIT T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- medulla oblongata: 108 nTPM
- white matter: 103 nTPM
- pons: 83 nTPM
- thalamus: 79 nTPM
- cerebellum: 78 nTPM
- midbrain: 78 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.92
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage response
- negative regulation of macroautophagy
- negative regulation of neuron apoptotic process
- neuron differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Protein kinase-like domain superfamily
- With No Lysine (K) Ser/Thr Protein Kinase
- Protein kinase domain
- Nuclear receptor-binding protein 2, pseudokinase domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NRBP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NRBP2 as an antibody target. Whether an autoantibody or antibody against NRBP2 could matter depends on whether native NRBP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NRBP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NRBP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...